Turkey is a hub for IgG4 Related Disease (IgG4 RD) treatment, with Hisar Hospital Intercontinental and Medical Park Antalya Hospital Complex leading in therapies like immunotherapy and minimally invasive surgery. Hisar Hospital, accredited by the Joint Commission International, attracts over 500,000 patients annually due to its specialized care.
Medical Park Antalya, with its International Health Tourism Authorization Certificate, focuses on orthopedics and transplantology. Success rates for early-stage IgG4 RD treatments are high, reflecting Turkey's healthcare excellence.